ABSTRACT:2,6-Dichlorophenyl methylsulfone (2,6-diClPh-MeSO 2 ) is a potent olfactory toxicant reported to induce endoplasmic reticulum (ER) stress, caspase activation, and extensive cell death in mice. The aim of the present study was to examine cytochrome P450 (P450)-dependent bioactivation, nonprotein sulfhydryl (NP-SH) levels, and early ultrastructural changes in mouse olfactory mucosa following an i.p. injection of 2,6-diClPh-MeSO 2 (32 mg/kg). A high covalent binding of 2,6-diClPh-14 C-MeSO 2 in olfactory mucosa S9 fraction was observed, and the CYP2A5/CYP2G1 substrates coumarin and dichlobenil significantly decreased the binding, whereas the CYP2E1 substrate chlorzoxazone had no effects. An increased bioactivation was detected in liver microsomes of mice pretreated with pyrazole, known to induce CYP2A4, 2A5, 2E1, and 2J, and addition of chlorzoxazone reduced this binding. 2,6-DiClPh-14 CMeSO 2 showed a marked covalent binding to microsomes of recombinant yeast cells expressing mouse CYP2A5 or human CYP2A6 compared with wild type. One and 4 h after a single injection of 2,6-diClPh-MeSO 2 , the NP-SH levels in the olfactory mucosa were significantly reduced compared with control, whereas there was no change in the liver. Ultrastructural studies revealed that ER, mitochondria, and secretory granules in nonneuronal cells were early targets 1 h after injection. We propose that lesions induced by 2,6-diClPh-MeSO 2 in the mouse olfactory mucosa were initiated by a P450-mediated bioactivation in the Bowman's glands and depletion of NP-SH levels, leading to disruption of ion homeostasis, organelle swelling, and cell death. The high expression of CYP2A5 in the olfactory mucosa is suggested to play a key role for the tissue-specific toxicity induced by 2,6-diClPh-MeSO 2 .The olfactory mucosa harbors a wide variety of xenobiotic-metabolizing enzymes including several cytochrome P450 (P450) forms; the most predominant are CYP2A3/5/10/13 and CYP2G1 (Ding and Kaminsky, 2003;Piras et al., 2003;Ling et al., 2004). The P450-mediated metabolism is generally regarded as a protection mechanism, and the high expression of drug-metabolizing P450s is most likely related to the clearance of odorants and other airborne chemicals. These enzymes may also protect the central nervous system against inhaled toxicants. P450 enzymes are, however, also central for the metabolic activation of foreign compounds into reactive, toxic metabolites, and olfactory P450s have been suggested to play a key role in the tissue-selective toxicity of drugs and chemicals in this tissue (Gaskell, 1990;Dahl and Hadley, 1991;Reed, 1993;Brittebo, 1997;Ding and Kaminsky, 2003). A decreased olfactory toxicity has been demonstrated after pretreatment with various P450 inhibitors (Brandt et al., 1990;Genter et al., 1994;Bahrami et al., 2000b). Many olfactory toxicants and carcinogens, including dichlobenil, coumarin, hexamethylphosphoramide, and the tobacco-specific 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone are preferentially bioactivated to reactive interme...